Merck nears deal for flu-prevention biotech Cidara
San Diego company’s lead drug is a potential alternative to vaccines for vulnerable patients
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Cidara
since
auto-detected in 1 stories
23 days ago
page 1 of 1